National Institute of Pharmaceutical Education and Research Hyderabad

What is the average package at National Institute of Pharmaceutical Education and Research Hyderabad?

National Institute of Pharmaceutical Education and Research Hyderabad recorded a median placement package of about Rs 6.68 LPA (Rs 6,68,000) in the 2025 drive reported under NIRF 2026, with the highest package reaching Rs 40 LPA (Rs 40,00,000). In that same cycle, 171 of 189 eligible students were placed, a placement rate of 90.48%. NIPER Hyderabad does not publish a single institute-wide "average" CTC figure in its NIRF disclosures, so the median is the most reliable central benchmark; portals that quote an overall average in the Rs 8-10 LPA band are estimating rather than citing an audited number. For an aspirant, the honest read is this: a NIPER Hyderabad postgraduate typically lands a research, regulatory or analytics role in the Rs 6-9 LPA range, with a small premium tier stretching well above that.

NIPER Hyderabad is a government Institute of National Importance focused on pharmaceutical sciences, and its placement outcomes are driven by core pharma and life-sciences recruiters rather than mass IT hiring. That shapes the numbers below: steady median outcomes near Rs 6-7 LPA, with the headline Rs 40 LPA reflecting a handful of exceptional offers, not the norm.

Branch/Course-Wise Package Breakdown

The table below maps NIPER Hyderabad's postgraduate disciplines (M.S. Pharm, M.Tech Pharm and MBA Pharm streams) to their relative package outcomes for the 2025 cycle. It answers the question "which branch at NIPER Hyderabad earns the most?" The institute discloses placement data at the postgraduate level rather than as audited per-branch CTC tables, so where an exact branch average is not officially published, the cell is marked accordingly and the institute median (Rs 6.68 LPA, 2025) is used as the anchor. Read the "relative tier" column as guidance on which streams cluster above or below that median.

The takeaway for 2025 is that NIPER Hyderabad's management and regulatory-facing streams (MBA Pharm, Regulatory Toxicology) and the data-leaning Pharmacoinformatics discipline tend to record the highest average CTCs, while Pharmaceutics and Pharmacology post the strongest placement rates. Core science branches such as Medicinal Chemistry and Pharmaceutical Analysis cluster around the institute median of roughly Rs 6.68 LPA. An applicant choosing a branch should weigh "highest average CTC" against "likelihood of being placed": the safest-to-place branches are not always the highest-paying.

Year-Wise Package Trend

This table tracks NIPER Hyderabad's package trajectory across the last four NIRF cycles so you can see whether outcomes are rising or holding. It answers "has the package at NIPER Hyderabad increased over the years?" Each row uses the median CTC, which is the figure NIPER reports to NIRF, alongside the placement rate and the highest offer for context. NIPER does not report an audited institute-wide average, so the average column reflects the median as the stable benchmark.

The trend shows a gentle, steady climb in the median over the three most recent years: from Rs 6.00 LPA (2023) to Rs 6.20 LPA (2024) to Rs 6.68 LPA (2025), an upward move of roughly 11% over two cycles. The Rs 8.85 LPA median reported for 2022 sat higher, partly reflecting a smaller, differently-composed graduating cohort. For an applicant, the practical signal is stability with modest growth: NIPER Hyderabad's median has held in the Rs 6-9 LPA band rather than swinging wildly, which is typical of a research-driven government pharma institute.

Notable Offers and Package Distribution

The standout number at NIPER Hyderabad is the Rs 40 LPA (Rs 40,00,000) highest package recorded in the 2025 cycle, the ceiling of a salary range that starts near Rs 2.5 LPA at the entry end. Most offers, however, concentrate around the Rs 6-7 LPA median, so the distribution is best understood as a broad mass-recruiter base with a thin premium tail rather than a uniformly high-paying batch.

The premium offers typically flow from cross-domain roles (data, analytics, regulatory and management functions) and from a few non-pharma names cited in placement coverage, while the volume of hiring comes from established pharmaceutical and CRO recruiters. Recurring recruiters across NIPER Hyderabad's drives include Dr. Reddy's Laboratories, Aurobindo Pharma, Hetero Drugs, Neuland Laboratories, Sun Pharma, Biocon, Lupin, Torrent, Allergan India, Aizant, Suven Life Sciences, TCS and WNS India. In the 2025 cycle, 171 of 189 eligible students were placed (90.48%) and 15 students opted for higher studies, which means the realistic expectation for an incoming student is a solid core-pharma or research-services role in the Rs 6-9 LPA band, with the Rs 40 LPA figure being the exception that a small number of top performers reach.